Company* (Country; Symbol)


Type/Product Area

Terms/Details (Date)

Affymetrix Inc. (AFFX)

Caliper Technologies Corp. (CALP)

Collaboration to develop and provide automated target preparation instruments for GeneChip and other products

New products will incorporate Caliper's expertise in high-throughput automation and microfluidics with Affymetrix's expert- ise in microarray technology; Affymetrix would market resulting products (1/13)

Argenta Discovery Ltd.* (UK)

TTP LabTech (unit of TTP Group plc; UK)

Deal to expand Argenta's capabilities through the incorporation of TTP's Acumen Explorer screening platform

The companies also will work to develop novel screening assays within the drug dis- covery process (1/29)

CombiMatrix Group (CMBX)

Cyrano Sciences Inc.*

Collaboration on the development of chemical sensors that merge CombiMatrix's microarray technology with Cyrano's electronic nose technology

They intend to develop products for sensing chemical agents in air and water; terms were not disclosed (1/12)

Concurrent Pharmaceuticals Inc.*

Intel Corp.

Collaboration to apply machine learning tools to the discovery and development of drugs

Intel Capital was among the investors in Concurrent's Series B financing, which was disclosed along with the alliance; terms of the deal were not disclosed (1/12)

PharmaStem Therapeutics Inc.*

Securacell Inc.*

Securacell gained a license to PharmaStem patents

Securacell will use the patents in its umbilical cord blood-banking business (2/5)

PharmaStem Therapeutics Inc.*

Newborn Blood Banking Inc.*

Newborn Blood Banking gained a license to PharmaStem's patent portfolio

The patents are in the area of umbilical cord and placental blood preservation; terms were not disclosed (1/30)


* Private companies are indicated with an asterisk.

Unless otherwise noted, the trading symbols listed for public companies are on the Nasdaq market.